SEER INC. - CLASS A COMMON STOCK

Seer Proteograph™ Enables Unprecedented Genetic Marker Mapping for Proteogenomics Studies to Advance Drug and Biomarker Discovery

06 фев 2024 07:00:00 Источник Nasdaq GlobeNewswire

Seer to Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024

01 фев 2024 15:05:00 Источник Nasdaq GlobeNewswire

Seer to Present at the J.P. Morgan 42nd Annual Health Care Conference

21 дек 2023 15:05:00 Источник Nasdaq GlobeNewswire

Seer to Present at the Canaccord MedTech, Diagnostics and Digital Health & Services Forum

10 ноя 2023 08:00:29 Источник Nasdaq GlobeNewswire

Seer Wins Proteomics Solution of the Year by BioTech Breakthrough and Named #5 on Deloitte Technology Fast 500

08 ноя 2023 08:00:00 Источник Nasdaq GlobeNewswire

Seer Reports Third Quarter 2023 Financial Results

07 ноя 2023 15:05:08 Источник Nasdaq GlobeNewswire

Seer Announces Addition of Panome Bio to Centers of Excellence (COE) Program

01 ноя 2023 08:00:00 Источник Nasdaq GlobeNewswire

Seer to Report Third Quarter 2023 Financial Results on November 7, 2023

19 окт 2023 15:05:00 Источник Nasdaq GlobeNewswire

Seer to Participate in Upcoming September Investor Conferences

08 сен 2023 15:05:00 Источник Nasdaq GlobeNewswire

Seer Reports Second Quarter 2023 Financial Results

08 авг 2023 15:05:01 Источник Nasdaq GlobeNewswire

Seer to Present at the Canaccord Genuity 43rd Annual Growth Conference

27 июл 2023 15:05:00 Источник Nasdaq GlobeNewswire

Seer to Report Second Quarter 2023 Financial Results on August 8, 2023

13 июл 2023 15:05:00 Источник Nasdaq GlobeNewswire

Seer Collaborates to Make Scalable, Unbiased Proteomics Accessible to More Researchers via new Seer Technology Access Center

07 июн 2023 08:00:18 Источник Nasdaq GlobeNewswire

Seer Launches the Proteograph XT Assay Kit: Allowing Labs to Easily Expand Their View of the Proteome and Scale Their Studies

01 июн 2023 08:00:00 Источник Nasdaq GlobeNewswire

Seer Reports First Quarter 2023 Financial Results

09 май 2023 15:05:01 Источник Nasdaq GlobeNewswire

Seer to Report First Quarter 2023 Financial Results on May 9, 2023

20 апр 2023 15:05:00 Источник Nasdaq GlobeNewswire

Seer’s Proteograph™ Product Suite identifies undiscovered links between protein variants and lung cancer progression

29 мар 2023 13:00:00 Источник Nasdaq GlobeNewswire

Seer Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Full Year 2023 Outlook

02 мар 2023 15:05:01 Источник Nasdaq GlobeNewswire

Seer to Present at the Cowen 43rd Annual Health Care Conference

21 фев 2023 15:30:00 Источник Nasdaq GlobeNewswire

Seer to Report Fourth Quarter and Full Year 2022 Financial Results on March 2, 2023

09 фев 2023 15:05:00 Источник Nasdaq GlobeNewswire